Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1952 1
1955 1
1965 1
1967 1
1968 1
1970 2
1971 1
1972 1
1975 1
1979 2
1982 1
1990 2
1991 1
1994 1
1995 2
1996 1
1997 2
1999 2
2000 1
2001 1
2002 4
2003 2
2004 2
2005 2
2006 6
2007 4
2008 6
2009 5
2010 7
2011 2
2012 7
2013 13
2014 7
2015 10
2016 3
2017 6
2018 8
2019 7
2020 6
2021 7
2022 2
2023 10
2024 3
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

150 results

Results by year

Filters applied: . Clear all
Page 1
Multistate point-prevalence survey of health care-associated infections.
Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, Lynfield R, Maloney M, McAllister-Hollod L, Nadle J, Ray SM, Thompson DL, Wilson LE, Fridkin SK; Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team. Magill SS, et al. Among authors: ray sm. N Engl J Med. 2014 Mar 27;370(13):1198-208. doi: 10.1056/NEJMoa1306801. N Engl J Med. 2014. PMID: 24670166 Free PMC article.
Changes in Prevalence of Health Care-Associated Infections in U.S. Hospitals.
Magill SS, O'Leary E, Janelle SJ, Thompson DL, Dumyati G, Nadle J, Wilson LE, Kainer MA, Lynfield R, Greissman S, Ray SM, Beldavs Z, Gross C, Bamberg W, Sievers M, Concannon C, Buhr N, Warnke L, Maloney M, Ocampo V, Brooks J, Oyewumi T, Sharmin S, Richards K, Rainbow J, Samper M, Hancock EB, Leaptrot D, Scalise E, Badrun F, Phelps R, Edwards JR; Emerging Infections Program Hospital Prevalence Survey Team. Magill SS, et al. Among authors: ray sm. N Engl J Med. 2018 Nov 1;379(18):1732-1744. doi: 10.1056/NEJMoa1801550. N Engl J Med. 2018. PMID: 30380384 Free PMC article.
Three months of rifapentine and isoniazid for latent tuberculosis infection.
Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, Hackman J, Hamilton CD, Menzies D, Kerrigan A, Weis SE, Weiner M, Wing D, Conde MB, Bozeman L, Horsburgh CR Jr, Chaisson RE; TB Trials Consortium PREVENT TB Study Team. Sterling TR, et al. N Engl J Med. 2011 Dec 8;365(23):2155-66. doi: 10.1056/NEJMoa1104875. N Engl J Med. 2011. PMID: 22150035 Free article. Clinical Trial.
Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections - United States.
Kourtis AP, Hatfield K, Baggs J, Mu Y, See I, Epson E, Nadle J, Kainer MA, Dumyati G, Petit S, Ray SM; Emerging Infections Program MRSA author group; Ham D, Capers C, Ewing H, Coffin N, McDonald LC, Jernigan J, Cardo D. Kourtis AP, et al. Among authors: ray sm. MMWR Morb Mortal Wkly Rep. 2019 Mar 8;68(9):214-219. doi: 10.15585/mmwr.mm6809e1. MMWR Morb Mortal Wkly Rep. 2019. PMID: 30845118 Free PMC article.
Tobramycin-induced hepatotoxicity.
Nisly SA, Ray SM, Moye RA. Nisly SA, et al. Among authors: ray sm. Ann Pharmacother. 2007 Dec;41(12):2061-5. doi: 10.1345/aph.1K266. Epub 2007 Oct 23. Ann Pharmacother. 2007. PMID: 17956959
Indacaterol: a novel long-acting β(2) -agonist.
Ray SM, McMillen JC, Treadway SA, Helmer RS, Franks AS. Ray SM, et al. Pharmacotherapy. 2012 May;32(5):456-74. doi: 10.1002/j.1875-9114.2012.01025.x. Epub 2012 Apr 12. Pharmacotherapy. 2012. PMID: 22499359 Review.
Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis Disease.
Haley CA, Schechter MC, Ashkin D, Peloquin CA, Peter Cegielski J, Andrino BB, Burgos M, Caloia LA, Chen L, Colon-Semidey A, DeSilva MB, Dhanireddy S, Dorman SE, Dworkin FF, Hammond-Epstein H, Easton AV, Gaensbauer JT, Ghassemieh B, Gomez ME, Horne D, Jasuja S, Jones BA, Kaplan LJ, Khan AE, Kracen E, Labuda S, Landers KM, Lardizabal AA, Lasley MT, Letzer DM, Lopes VK, Lubelchek RJ, Patricia Macias C, Mihalyov A, Misch EA, Murray JA, Narita M, Nilsen DM, Ninneman MJ, Ogawa L, Oladele A, Overman M, Ray SM, Ritger KA, Rowlinson MC, Sabuwala N, Schiller TM, Schwartz LE, Spitters C, Thomson DB, Tresgallo RR, Valois P, Goswami ND; BPaL Implementation Group. Haley CA, et al. Among authors: ray sm. Clin Infect Dis. 2023 Oct 5;77(7):1053-1062. doi: 10.1093/cid/ciad312. Clin Infect Dis. 2023. PMID: 37249079 Free PMC article.
Data Which Call for Action.
Ray SM. Ray SM. Clin Infect Dis. 2021 Jul 1;73(1):e206-e207. doi: 10.1093/cid/ciaa1587. Clin Infect Dis. 2021. PMID: 33064126 No abstract available.
150 results